Traws Pharma files legal opinion for $3.1M at-the-market stock offering

Traws Pharma, Inc. completed a legal opinion filing for an at-the-market offering of up to $3.1 million in common stock shares under a Form S-3 registration statement with Citizens JMP Securities as sales agent. The offering provides the pharmaceutical company with capital raising flexibility through the public markets.